REMTULLA GETS MORE PHARMACEUTICAL BUSINESS
By Adnews Staff
Toronto-based Remtulla & Associates is now the agency-of-record in Canada for Hoffmann La Roche's cardiovascular therapy drugs. The agency was given the Activase account last week without a review. Remtulla has been handling other cardiovascular drugs for Hoffmann La Roche since late last year after a competition with three other agencies. The other drugs are Posicor, a calcium channel antagonist and Inhibace, an ACE inhibitor. Over the past few months Remtulla has also picked up an account from SmithKline Beecham, as well as additional business from Knoll Pharma, Eli-Lilly and Allergan.
« Back Next »
Comments
blog comments powered by Disqus